Predicate |
Object |
contentType |
Comment|Journal Article |
endingPage |
40 |
issn |
1361-2611 |
issueIdentifier |
1 |
pageRange |
38-40 |
publicationName |
Evidence-based Cardiovascular Medicine |
startingPage |
38 |
bibliographicCitation |
Bolognese L, Singh D. Adding tirofiban to standard pretreatment does not alter outcomes for people with non ST-elevation ACS undergoing early invasive therapy. Evid Based Cardiovasc Med. 2006 Mar;10(1):38–40. doi: 10.1016/j.ebcm.2006.01.013. PMID: 16530677. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5630483cde426b7d5a215260575c0a98 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2162d8345e8f3e2d3def01ddaf3c8854 |
date |
200603 |
identifier |
https://pubmed.ncbi.nlm.nih.gov/16530677 https://doi.org/10.1016/j.ebcm.2006.01.013 |
isPartOf |
https://portal.issn.org/resource/ISSN/1361-2611 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32681 |
language |
English |
source |
https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/ |
title |
Adding tirofiban to standard pretreatment does not alter outcomes for people with non ST-elevation ACS undergoing early invasive therapy |